Logo 1 Logo 2

Clinical Trial Details

Trial ID: L4432
Source ID: NCT04932213
Associated Drug: Tropicamide Ophthalmic
Title: Effect of Tropicamide 0.5% vs Tropicamide 1% on Intraocular Pressure of Diabetic Patients
Acronym:
Status: COMPLETED
Study Results: NO
Results:
Conditions: Type 2 Diabetes Mellitus|Type 1 Diabetes Mellitus
Interventions: DRUG: Tropicamide Ophthalmic
Outcome Measures: Primary: Change from baseline in Intraocular pressure (IOP), The intraocular pressure is measured by Goldmann applanation tonometry, Before intervention, 30 minutes after intervention|Change from baseline in pupillary diameter, The diameter of the participants' pupil is measured by Scheimpflug camera (Oculus Pentacam); Autorefractokeratometer (TOMEY RC-5000 and Topcon KR-1), Before intervention, 30 minutes after intervention | Secondary: Change from baseline in Keratometry, The keratometry is obtained by Scheimpflug camera (Oculus Pentacam); Autorefractokeratometer (TOMEY RC-5000 and Topcon KR-1), Before intervention, 30 minutes after intervention|Change from baseline in anterior chamber depth (ACD), The ACD is measured by Scheimpflug camera (Oculus Pentacam), Before intervention, 30 minutes after intervention|Change from baseline in anterior chamber volume (ACV), The ACV is measured by Scheimpflug camera (Oculus Pentacam), Before intervention, 30 minutes after intervention|Change from baseline in anterior chamber angle (ACA), The ACA is measured by Scheimpflug camera (Oculus Pentacam), Before intervention, 30 minutes after intervention|Change from baseline in central corneal thickness (CCT), The CCT is measured by Scheimpflug camera (Oculus Pentacam), Before intervention, 30 minutes after intervention
Sponsor/Collaborators: Sponsor: Semnan University of Medical Sciences
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE3
Enrollment: 98
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Start Date: 2021-07-07
Completion Date: 2021-11-07
Results First Posted:
Last Update Posted: 2021-11-19
Locations: Kowsar Semnan Research and Medical Training Center, Semnan, 3514799442, Iran, Islamic Republic of
URL: https://clinicaltrials.gov/show/NCT04932213